Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.41	1.7	8.26	10.36	6.54
Short-Term Investments	0.57	0.02	0.08	0.09	0.9
Cash & Cash Equivalents	0.98	1.72	8.34	10.45	7.45
Cash Growth	-43.06%	-79.35%	-20.20%	40.36%	7.65%
Receivables	6.58	6.04	5.25	6.32	6.1
Inventory	6.03	10.13	10.62	11.99	13.73
Other Current Assets	-4.13	-8.28	-8.43	-10.21	-11.89
Total Current Assets	9.45	9.61	15.78	18.56	15.39
Property, Plant & Equipment	22.03	14.21	4.15	1.94	1.85
Long-Term Investments	0.31	0.31	0.31	0.31	0.31
Goodwill and Intangibles	2.93	17.1	18.15	3.47	3.19
Other Long-Term Assets	26.5	23.66	22.27	21.92	22.15
Total Long-Term Assets	51.77	55.28	44.88	27.64	27.5
Total Assets	61.22	64.89	60.66	46.2	42.89
Accounts Payable	3.17	1.61	1.49	0.96	1.37
Deferred Revenue	50.89	45.59	40.63	36.38	32.51
Current Debt	1.61	2.72	2.21	3.38	3.1
Other Current Liabilities	-34.82	-30.43	-23.26	-24.3	-21.55
Total Current Liabilities	20.86	19.48	21.07	16.41	15.43
Long-Term Debt	9.28	8.89	0.61	2.86	5.86
Other Long-Term Liabilities	42.11	38.04	34.79	29.59	28.55
Total Long-Term Liabilities	51.39	46.93	35.4	32.45	34.41
Total Liabilities	72.25	66.41	56.48	48.87	49.84
Total Debt	10.9	11.61	2.82	6.24	8.96
Debt Growth	-6.18%	311.68%	-54.79%	-30.32%	-30.81%
Retained Earnings	-31.16	-21.64	-16.74	-18.82	-22.44
Shareholders' Equity	-11.03	-1.52	4.18	-2.67	-6.95
Net Cash / Debt	-9.92	-9.89	5.52	4.21	-1.51
Net Cash / Debt Growth	-	-	31.08%	-	-
Net Cash Per Share	-1.19	-1.17	0.66	0.52	-0.18
Working Capital	-11.41	-9.87	-5.29	2.14	-0.04
Book Value Per Share	-1.32	-0.18	0.51	-0.35	-0.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).